Jump to main content
Jump to site search

Issue 3, 2018
Previous Article Next Article

Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease

Author affiliations

Abstract

A key feature of peripheral arterial disease (PAD) is damage to endothelial cells (ECs), resulting in lower limb pain and restricted blood flow. Recent preclinical studies demonstrate that the transplantation of ECs via direct injection into the affected limb can result in significantly improved blood circulation. Unfortunately, the clinical application of this therapy has been limited by low cell viability and poor cell function. To address these limitations we have developed an injectable, recombinant hydrogel, termed SHIELD (Shear-thinning Hydrogel for Injectable Encapsulation and Long-term Delivery) for cell transplantation. SHIELD provides mechanical protection from cell membrane damage during syringe flow. Additionally, secondary in situ crosslinking provides a reinforcing network to improve cell retention, thereby augmenting the therapeutic benefit of cell therapy. In this study, we demonstrate the improved acute viability of human induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) following syringe injection delivery in SHIELD, compared to saline. Using a murine hind limb ischemia model of PAD, we demonstrate enhanced iPSC-EC retention in vivo and improved neovascularization of the ischemic limb based on arteriogenesis following transplantation of iPSC-ECs delivered in SHIELD.

Graphical abstract: Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Sep 2017, accepted on 23 Jan 2018 and first published on 25 Jan 2018


Article type: Paper
DOI: 10.1039/C7BM00883J
Citation: Biomater. Sci., 2018,6, 614-622
  •   Request permissions

    Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease

    A. A. Foster, R. E. Dewi, L. Cai, L. Hou, Z. Strassberg, C. A. Alcazar, S. C. Heilshorn and N. F. Huang, Biomater. Sci., 2018, 6, 614
    DOI: 10.1039/C7BM00883J

Search articles by author

Spotlight

Advertisements